Hrt Financial LP Bio Rad Laboratories, Inc. Transaction History

Hrt Financial LP

$17 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$304.11 - $351.99 $107,959 - $124,956	355 Added 20.91%	2,053 $710,000
Q4 2023 Feb 09, 2024	SELL	$269.37 - $365.04 $4.43 Million - $6 Million	-16,447 Reduced 90.64%	1,698 $548,000
Q3 2023 Nov 13, 2023	BUY	$350.25 - $422.63 $5.37 Million - $6.47 Million	15,320 Added 542.3%	18,145 $6.5 Million
Q2 2023 Aug 11, 2023	SELL	$359.49 - $486.4 $1.22 Million - $1.66 Million	-3,406 Reduced 54.66%	2,825 $1.07 Million
Q1 2023 May 12, 2023	BUY	$418.69 - $503.0 $2.03 Million - $2.44 Million	4,856 Added 353.16%	6,231 $2.98 Million
Q4 2022 Feb 10, 2023	BUY	$351.71 - $456.01 $13,716 - $17,784	39 Added 2.92%	1,375 $578,000
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $551,220 - $752,515	1,336 New	1,336 $557,000
Q2 2022 Aug 12, 2022	SELL	$463.67 - $597.16 $432,604 - $557,150	-933 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$524.57 - $735.42 $2.4 Million - $3.36 Million	-4,572 Reduced 83.05%	933 $525,000
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $3.9 Million - $4.37 Million	5,505 New	5,505 $4.16 Million
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $3.26 Million - $4.09 Million	-4,951 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $2.85 Million - $3.21 Million	4,951 New	4,951 $3.19 Million
Q1 2021 May 17, 2021	SELL	$547.01 - $662.35 $877,404 - $1.06 Million	-1,604 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $819,130 - $1.03 Million	1,604 New	1,604 $935,000
Q3 2020 Nov 13, 2020	SELL	$454.43 - $535.6 $10.2 Million - $12 Million	-22,444 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $7.52 Million - $11.1 Million	22,444 New	22,444 $10.1 Million

Others Institutions Holding BIO

# of Institutions

461

Shares Held

19.6M

Call Options Held

23.2K

Put Options Held

37.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.24B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account